Iodine-Labeled Compounds from Natural Sources Show Promise in Cancer Therapy | Radiopharmaceuticals for Dual Diagnosis and Treatment

In this episode of SciBud, we dive into the groundbreaking role of radioiodine in cancer therapy, exploring a compelling review that highlights the innovative use of iodine-labeled compounds sourced from nature. Join your host Rowan as we unpack how radioactive isotopes like iodine-131 and iodine-125 are revolutionizing oncology, providing both diagnostic insights and targeted therapeutic radiation—effectively attacking tumors while sparing healthy tissue. We’ll examine the promising findings from various clinical studies, focusing on how compounds such as curcumin and hypericin could lead to more effective and less toxic treatments through advanced labeling techniques. While the potential of these radioligands is significant, we’ll also discuss the challenges and critiques presented in the review, including issues of reproducibility and bioavailability. Tune in for an engaging exploration of how traditional medicinal compounds are being transformed by modern technology in the quest for precision medicine and better cancer care! Link to episode page with article citation: www.scibud.media/podcast/season/2025/episode/162